Breaking News - The Fly

Open Search

ONCT

Oncternal Therapeutics

$

()

Oncternal announces first patient dosed in fourth cohort of study of ONCT-534

ONCT

4/18/2024 - 09:11am

Oncternal Therapeutics price target lowered by $2 at H.C. Wainwright, here's why

ONCT

4/15/2024 - 06:50am

Oncternal Therapeutics files $250M mixed securities shelf

ONCT

3/8/2024 - 16:43pm

Oncternal Therapeutics reports Q4 EPS ($3.11), consensus (3.07)

ONCT

3/7/2024 - 16:06pm

Oncternal Therapeutics reports inducement award under Nasdaq listing rule

ONCT

2/1/2024 - 09:02am

Oncternal Therapeutics target adjusted to $30 from $2 at H.C. Wainwright

ONCT

1/29/2024 - 06:06am

Oncternal enrolls patients into third dosing cohort of Phase 1/2 trial

ONCT

1/8/2024 - 09:21am

Oncternal Therapeutics trading halted, news pending

ONCT

1/5/2024 - 19:50pm

Oncternal Therapeutics to effect 1-for-20 reverse stock split

ONCT

1/4/2024 - 09:05am

Oncternal Therapeutics reports inducement award under Nasdaq listing rule

ONCT

1/2/2024 - 09:07am

Oncternal Therapeutics provides update on Phase 1/2 study of lymphoma candidate

ONCT

12/26/2023 - 09:03am

Oncternal Therapeutics upgraded to Buy from Hold at Brookline

ONCT

12/4/2023 - 08:48am

Oncternal Therapeutics announces Fast Track designation for ONCT-534

ONCT

10/26/2023 - 09:04am

Oncternal Therapeutics appoints Matthew Smith to Prostate Cancer SAB

ONCT

10/25/2023 - 09:09am

Oncternal Therapeutics doses first patient in ONCT-534 study

ONCT

10/5/2023 - 16:05pm